2026년 대한위암학회 국제학술대회 (KINGCA WEEK 2026) (2일차)
5.0점
일반 5.0
- 주최
- 대한위암학회
- 일자
- 2026-09-18
- 장소
- 롯데호텔 서울 2층
- 수강료
- 500,000원 구분별
수강료 구분별 상세보기
- [사전등록] KGCA회원(IGCA회원):20만원/KGCA회원(IGCA비회원):30만원/KGCA공동심포지엄참여학회회원:30만원/KGCA비회원:40만원/연구원,간호사,군의관,공중보건의:5만원/전공의,원로회원,학생,초청연자및좌장:무료[현장등록] KGCA회원(IGCA회원):30만원/KGCA회원(IGCA비회원):40만원/KGCA공동심포지엄참여학회회원:40만원/KGCA비회원:50만원/연구원,간호사,군의관,공중보건의:10만원/전공의,원로회원,학생 무료
평점 구성
연수평점은 3년 24점·연 8점 상한·필수 2점 요건이 있습니다. 이 행사 들으면 올해 상한까지 몇 점? →
세부 일정 (95강)
- 09:00~09:20 Efforts toward the unification and harmonization of staging systems Crystal Ballroom 1+2 James Brierley(The University of Toronto, Canada)
- 09:20~09:40 9th TNM for gastric cancer: AJCC viewpoint Crystal Ballroom 1+2 Haejin In(Rutgers Cancer Institute of New Jersey, USA)
- 09:40~10:00 Considerations for incorporating biomarkers in gastric cancer staging Crystal Ballroom 1+2 Hye Seung Lee(Seoul National University)
- 10:00~10:20 Global perspectives on gastric cancer prevention: Latest advances Crystal Ballroom 1+2 Jin Young Park(IARC (International Agency for Research on Cancer), France)
- 10:20~10:30 Break Crystal Ballroom 1+2 ()
- 10:30~11:00 Advances in chemotherapy for gastric cancer: Future perspectives Crystal Ballroom 1+2+3+Emerald Room Kohei Shitara(National Cancer Center Hospital East, Japan)
- 11:00~11:30 The evolution and future prospects of gastric cancer treatment in Japan Crystal Ballroom 1+2+3+Emerald Room Masanori Terashima(Shizuoka Cancer Center, Japan)
- 11:30~12:00 KGCA General Assembly Crystal Ballroom 1+2+3+Emerald Room ()
- 12:00~12:10 Break Crystal Ballroom 1+2 ()
- 12:10~13:00 Bedside stapling with Tri-Staple Reinforced Reload Crystal Ballroom 1+2 Hayemin Lee(The Catholic University of Korea)
- 13:00~13:20 Reduced-port robotic gastrectomy: Expanding the feasibility of less invasive gastrectomy Crystal Ballroom 1+2 Yoo Min Kim(Yonsei University)
- 13:20~13:40 Single-port robotic gastrectomy using the da Vinci SP system: Current status and future perspectives Crystal Ballroom 1+2 Takeshi Omori(Osaka International Cancer Institute, Japan)
- 13:40~14:00 Why biology matters for surgical decision-making in PD-L1-positive advanced gastric cancer Crystal Ballroom 1+2 Yoon Young Choi(Soonchunhyang University)
- 14:00~14:20 Toward precision management of peritoneal metastasis in gastric cancer: Integrating NIPS, conversion surgery, and CLDN18.2-targeted therapy Crystal Ballroom 1+2 Hiroharu Yamashita(Jichi Medical University, Japan)
- 14:20~14:40 Break Crystal Ballroom 1+2 ()
- 14:40~15:00 Robotic gastrectomy interest group Crystal Ballroom 1+2 Maria Bencivenga(University of Verona, Italy)
- 15:00~15:20 Peritoneal carcinomatosis group Crystal Ballroom 1+2 Jimmy So(National University Hospital, Singapore)
- 15:20~15:40 Poorly cohesive gastric cancer: IGCA working group update & WHO classification 6th edition Crystal Ballroom 1+2 Heike I. Grabsch, Netherlands(Maastricht University Medical Center)
- 15:40~16:00 EGC working group Crystal Ballroom 1+2 Hyunsoo Chung(Seoul National University)
- 16:00~16:20 Break Crystal Ballroom 1+2 ()
- 09:00~09:20 Real-world robotic reconstruction for western patients Crystal Ballroom 3 Andrés Navarrete(Clínica Alemana de Santiago, Chile)
- 09:20~09:40 Minimally invasive conversion surgery for advanced gastric cancer Crystal Ballroom 3 Chang Min Lee(Korea University)
- 09:40~10:00 Current status of surgical treatment in Mongolia Crystal Ballroom 3 Enkhamgalan Tsiiregzen(Intermed Hospital, Mongolia)
- 10:00~10:20 Laparoscopic distal gastrectomy with D2 plus No. 13 lymph node dissection for gastric cancer with duodenal invasion Crystal Ballroom 3 Shin Akagawa(Kitakyushu Municipal Medical Center, Japan)
- 10:20~10:30 Break Crystal Ballroom 3 ()
- 10:30~11:00 Advances in chemotherapy for gastric cancer: Future perspectives Crystal Ballroom 1+2+3+Emerald Room Kohei Shitara(National Cancer Center Hospital East, Japan)
- 11:00~11:30 The evolution and future prospects of gastric cancer treatment in Japan Crystal Ballroom 1+2+3+Emerald Room Masanori Terashima(Shizuoka Cancer Center, Japan)
- 11:30~12:00 KGCA General Assembly Crystal Ballroom 1+2+3+Emerald Room ()
- 12:00~12:10 Break Crystal Ballroom 3 ()
- 12:10~12:35 Why Perioperative Systemic Control Matters Crystal Ballroom 3 Do-Youn Oh(Seoul National University)
- 12:35~13:00 From Curative Surgery to Curative Pathway: Lessons from MATTERHORN Crystal Ballroom 3 Masanori Terashima(Shizuoka Cancer Center, Japan)
- 13:00~13:20 Total gastrectomy in the elderly: A nationwide analysis of surgical outcomes (KLASS-15) Crystal Ballroom 3 Sung Il Choi(Kyung Hee University)
- 13:20~13:40 Time-sequencing prediction of postoperative complication Crystal Ballroom 3 Souya Nunobe(Cancer Institute Hospital, Japan)
- 13:40~14:00 Imaging predictors of treatment response to immunotherapy Crystal Ballroom 3 Myung-Won You(Yonsei University)
- 14:00~14:20 Current evidence of sentinel node navigation surgery Crystal Ballroom 3 Bang Wool Eom(National Cancer Center)
- 14:20~14:40 Break Crystal Ballroom 3 ()
- 14:40~15:00 Surgical management of oligometastatic gastric cancer Crystal Ballroom 3 Carlos García(Hospital San Borja Arriarán, Chile)
- 15:00~15:20 STOPGAP I and II - iterative intraperitoneal chemotherapy and conversion surgery: Transforming unresectable disease to resectable Crystal Ballroom 3 Maheswari Senthil(UC Irvine, USA)
- 15:20~15:40 New horizons in peritoneal metastasis: Combining intraperitoneal paclitaxel with immunotherapy and targeted agents Crystal Ballroom 3 Joji Kitayama(Japan Institute of Health Security, Japan)
- 15:40~16:00 Phase 3 RCT using bidirectional chemotherapy for GCPM Crystal Ballroom 3 So Hyun Kang(Seoul National University)
- 16:00~16:20 Break Crystal Ballroom 3 ()
- 09:00~09:20 Designing a personalized digital exercise and nutrition rehabilitation program after gastrectomy: Lessons from a 12-month multicenter randomized trial Emerald Room Inah Kim(Hallym University)
- 09:20~09:40 The use of WECARE program for patients with a gastrectomy for gastric cancer Emerald Room Sang Ho Jeong(Gyeongsang National University)
- 09:40~10:00 Follow-up quality of life after reduced-port gastrectomy in Japan Emerald Room Kohei Fujita(Nagoya City University, Japan)
- 10:00~10:20 ERAS application and long-term outcome after reduced-port gastrectomy in Korea Emerald Room Jawon Hwang(Yonsei University)
- 10:20~10:30 Break Emerald Room ()
- 10:30~11:00 Advances in chemotherapy for gastric cancer: Future perspectives Crystal Ballroom 1+2+3+Emerald Room Kohei Shitara(National Cancer Center Hospital East, Japan)
- 11:00~11:30 The evolution and future prospects of gastric cancer treatment in Japan Crystal Ballroom 1+2+3+Emerald Room Masanori Terashima(Shizuoka Cancer Center, Japan)
- 11:30~12:00 KGCA General Assembly Crystal Ballroom 1+2+3+Emerald Room ()
- 12:00~12:10 Break Emerald Room ()
- 12:10~13:00 Advancing Hemostatic Management in Gastrointestinal Surgery with ActiClot Emerald Room Dong-Wook Kim(Dankook University)
- 13:00~13:20 Discovery of prognostic factors through integration of deep learning–based pathology image analysis and molecular biomarker profiling in gastric cancer Emerald Room Sung Hak Lee(The Catholic University of Korea)
- 13:20~13:40 Optimal treatment extent for remnant gastric cancer: Multicenter evidence from nodal and survival analyses Emerald Room In-Seob Lee(University of Ulsan)
- 13:40~14:00 Clinical outcomes and prognostic factors in elderly patients aged ≥75 years with early gastric cancer after endoscopic resection: A nationwide cohort study Emerald Room Seokin Kang(Inje University)
- 14:00~14:20 Correlation between glycosylation of PD-L1 and prognosis in gastric cancer, and immunohistochemical expression Emerald Room Jinho Shin(University of Ulsan)
- 14:20~14:40 Break Emerald Room ()
- 14:40~15:00 Minimally invasive double flap technique procedure for the anti-reflux mechanism after proximal gastrectomy Emerald Room Dong Jin Kim(The Catholic University of Korea)
- 15:00~15:20 Applying anti-reflux reconstruction in real-world practice Emerald Room Sang-Hoon Ahn(Sungkyunkwan University)
- 15:20~15:40 Novel surgical strategies for anti-reflux reconstruction Emerald Room Yun-Suhk Suh(Seoul National University)
- 15:40~16:00 Is it necessary to modify double-flap reconstruction technique? Emerald Room Long Vo Duy(University Medical Center at Ho Chi Minh City, Vietnam)
- 16:00~16:20 Break Emerald Room ()
- 09:00~09:20 Redefining the Role of P-CAB_From GERD to Gastritis and Beyond Sapphire Ballroom 1 Hyunsoo Chung(Seoul National University)
- 09:20~09:27 (구연)Clinical Performance of Diagnostic Assistance Software for Gastric Neoplasm Detection and Invasion-Depth Prediction: A Multi-Reader External-Validation Study Using Endoscopic Videos from Three Tertiary Centers Sapphire Ballroom 1 Yuna KIM(Yonsei University College of Medicine)
- 09:27~09:34 (구연)Clinical criteria for Selective Chest CT in Gastric Cancer: A Multicenter Retrospective Study Sapphire Ballroom 1 Sojung KIM(Seoul St. Mary)
- 09:34~09:41 (구연)Acid neutralizing method improves diagnostic accuracy for map-like redness after Helicobacter pylori eradication Sapphire Ballroom 1 Tetsuya UEO(Oita Red Cross Hospital, Japan)
- 09:41~09:48 (구연)Multiplex Immunohistochemistry-Based Immune Profiling Identifies PD L1⁺ M2 Macrophages as Independent Prognostic Markers in Advanced Gastric Cancer Sapphire Ballroom 1 Deokgeun KIM(Samsung Medical Center)
- 09:48~09:55 (구연)International Multi-Institutional Validation Study of Novel Deep Learning Convolutional Neural Network Model to Predict Risk of Peritoneal Carcinomatosis in Gastric Cancer Sapphire Ballroom 1 Arsha OSTOWARI(Irvine Medical Center, USA)
- 09:55~10:02 (구연)Deep Learning–Based Detection of Peritoneal Metastasis in Gastric Cancer Using Computed Tomography Sapphire Ballroom 1 Han Hong LEE(Seoul St. Mary)
- 10:02~10:09 (구연)Therapeutic Value Index of Lymph Node Stations in Lower-Third Gastric Cancer Stratified by Tumor Depth: A Comparison with Middle-Third Tumors Sapphire Ballroom 1 MIN KYU KANG(Seoul National University Hospital)
- 10:09~10:16 (구연)Development and Validation of a Preoperative Nodal Stage Prediction Tool for Gastric Cancer Sapphire Ballroom 1 Oliver MAIDA(Hospital Clínico San Borja de Arriarán, Chile)
- 10:20~10:30 Break Sapphire Ballroom 1 ()
- 12:00~12:10 Break Sapphire Ballroom 1 ()
- 13:00~13:20 Follow up after gastrectomy - nutritional surveillance, cause of follow up-loss Sapphire Ballroom 1 Ji-Ho Park(Gyeongsang National University)
- 13:20~13:40 Early experience in robotic gastrectomy: Practical insights and clinical pearls for surgical assistants Sapphire Ballroom 1 Young Mo Jung(Pusan National University)
- 13:40~14:00 Red flag sign of early complications after gastric cancer surgery (From the perspective of ward nurse & NP) Sapphire Ballroom 1 Yujin Ahn(Yonsei University)
- 14:00~14:20 Perioperative nutrition in gastric cancer Sapphire Ballroom 1 Minji Han(Soonchunhyang University)
- 14:40~15:00 The Role of CLDN18.2 targeted therapy in Advanced Gastric Cancer: Real-World Experience Sapphire Ballroom 1 Yong Won Choi(Ajou University)
- 15:00~15:07 (구연)Real-World Evidence of Risk- and Tolerability-Adapted Adjuvant Chemotherapy Selection After Curative Gastrectomy for Stage II–III Gastric Cancer: A Korean Gastric Cancer Association-led Nationwide Survey Sapphire Ballroom 1 Jong Hyuk YUN(Soonchunhyang university cheonan hospital)
- 15:07~15:14 (구연)Short-term outcomes of neoadjuvant therapy for locally advanced Siewert type II/III adenocarcinoma of esophagogastric junction: A national, multicenter, prospective study Sapphire Ballroom 1 Jiabin ZHENG(Guangdong Provincial People)
- 15:14~15:21 (구연)A novel TRG-ypT-ypN 3D staging system for local advanced gastric cancer patients after neoadjuvant therapy: a multicenter real-world study Sapphire Ballroom 1 Yuchen LIU (Chinese PLA General Hospital, China)
- 15:21~15:28 (구연)Textbook Oncological Outcome in Locally Advanced Gastric Cancer With or Without Neoadjuvant Chemotherapy: A Single-Center Subanalysis of the PRODIGY Trial Sapphire Ballroom 1 Juno YOO(Asan Medical Center)
- 15:28~15:35 (구연)Assessing Efficacy and Pathological, Endoscopic, Radiologic Consistency in Localized dMMR Gastric Cancer Treated with Immune Checkpoint Inhibitor-based therapy or Chemotherapy Sapphire Ballroom 1 Pengfei ZHANG(West China Hospital, China)
- 15:35~15:42 (구연)Gastrojejunostomy as a Bridge to Neoadjuvant Chemotherapy for Obstructive Locally Advanced Gastric Cancer Sapphire Ballroom 1 Takayuki TSUJI(National Cancer Center Hospital East, Japan)
- 15:42~15:49 (구연)Impact of Perioperative Therapy on Pathologic Response and Survival Outcomes in Hepatoid Adenocarcinoma of Stomach Sapphire Ballroom 1 Liqiao CHEN(Peking University Cancer Hospital and Institute, China)
- 15:49~15:56 (구연)Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastases: A Single-Center Experience Sapphire Ballroom 1 Maria João CARDOSO(IPO Porto)
- 16:00~16:20 Break Sapphire Ballroom 1 ()
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Young-Woo Kim(National cancer Center)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Hee Sung Kim(CHA University)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Seung Jong Oh(Inha University)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Moon-Soo Lee(Eulji University)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Shin-Hoo Park(Eulji University)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Seong Gon Kim(Konyang University)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Yonghae Baik(Dongguk University)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Jong-Min Park(National Medical Center)
- 16:20~17:40 (좌장)Poster Presentation with Discussion Sapphire Ballroom 2+3+4 Ki Bum Park(The Catholic University of Korea)
비슷한 다른 연수교육
가까운 시기(±15일)에 열리는 온라인·동일 평점 이상·더 낮은 수강료 행사를 우선 추천해요. 부족하면 같은 주최·같은 달 행사로 채웠어요.
자주 묻는 질문
2026년 대한위암학회 국제학술대회 (KINGCA WEEK 2026) (2일차)의 연수평점은 몇 점인가요?
5.0평점입니다. 연 8점 상한 안에서 인정됩니다.
어디에서 열리나요?
서울특별시 롯데호텔 서울 2층에서 열리는 오프라인 행사입니다.
수강료는 얼마인가요?
500,000원입니다. 정확한 등록비·신청은 KMA/주최기관 원문 페이지에서 확인하세요.
MedPass 내 일정 관리에서 평점 계획을 세워보세요
이 교육을 내 일정함에 담고, 직전 3년 연수평점 계획까지 한 번에 관리할 수 있어요.
내 일정 관리로 →